• Markets
    • icon
  • Companies
HLA · ASX

Healthia Ltd (ASX:HLA)

AU$1.8

 0.0025 (0.139%)
ASX:Live
30/11/2023 12:00:00 AM
Near Resistance Near 52 Week High HALO Ords GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HLA Overview

HLA Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About HLA

Website

Healthia Ltd

Telephone

61.07.3180.4900

Address

Level 4 25 Montpelier Road East Tower Bowen Hills, Queensland (QLD) 4006

Description

Healthia Ltd. is a holding company, which engages in the operation and expansion of podiatry and physiotherapy clinics, and Business-to-Business businesses in Australia. It operates through the following segments: Feet and Ankles, Bodies and Minds, and Eyes and Ears. The Feet and Ankles segment offers podiatry services and podiatry related services including the manufacturing and sale of orthotics and podiatry related products. The Bodies and Minds segment is involved in physiotherapy and specialty hand therapy services. The Eyes and Ears segment focuses on optometry and audiology services. The company was founded on May 10, 2018 and is headquartered in Bowen Hills, Australia.

HLA Price Chart

Key Stats

Market Cap

AU$251.71M

PE

8.90

EV/EBITDA

5.9

Dividends Overview

DIV Yield

3.6%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.85 - 1.79

Trade Value (12mth)

AU$74,547.00

1 week

-0.14%

1 month

1.27%

YTD

41.14%

1 year

53.21%

All time high

2.43405

Key Fundamentals

EPS 3 yr Growth

-1.000%

EBITDA Margin

20.70%

Operating Cashflow

$23m

Free Cash Flow Return

8.10%

ROIC

2.00%

Interest Coverage

5.60

Quick Ratio

0.60

Other Data

Shares on Issue (Fully Dilluted)

148m

HALO Sector

Healthcare

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

HLA Announcements

Latest Announcements

Date Announcements

31 October 22

Acquisition Update and Settlement

×

Acquisition Update and Settlement

31 August 23

Preliminary Final Report

×

Preliminary Final Report

31 August 23

HLA enters into Scheme Implementation Deed with PEP

×

HLA enters into Scheme Implementation Deed with PEP

31 August 23

Becoming a substantial holder

×

Becoming a substantial holder

31 August 22

Preliminary Final Report

×

Preliminary Final Report

31 August 22

FY2022 Results Announcement

×

FY2022 Results Announcement

31 August 22

FY2022 Results Presentation

×

FY2022 Results Presentation

30 September 22

2022 Annual Report

×

2022 Annual Report

30 September 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 September 21

Abridged Acquisition and Capital Raising Presentation

×

Abridged Acquisition and Capital Raising Presentation

30 October 20

INVESTOR PRESENTATION - ACQUISITION AND EQUITY RAISING

×

INVESTOR PRESENTATION - ACQUISITION AND EQUITY RAISING

30 October 20

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 November 23

Scheme of Arrangement Legally Effective

×

Scheme of Arrangement Legally Effective

30 November 23

Suspension from Quotation

×

Suspension from Quotation

30 November 20

2020 AGM PRESENTATION

×

2020 AGM PRESENTATION

30 January 23

Trading Update & CFO & Joint Company Secretary Resignation

×

Trading Update & CFO & Joint Company Secretary Resignation

30 August 23

Notification of cessation of securities - HLA

×

Notification of cessation of securities - HLA

30 August 21

Appendix 4E and 2021 Annual Report to Shareholders

×

Appendix 4E and 2021 Annual Report to Shareholders

30 August 21

FY21 Results Investor Presentation

×

FY21 Results Investor Presentation

30 August 19

Appendix 4E & Annual Report to Shareholders

×

Appendix 4E & Annual Report to Shareholders

29 September 23

2023 Annual Report

×

2023 Annual Report

29 September 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 November 23

Supreme Court of NSW approves Scheme of Arrangement

×

Supreme Court of NSW approves Scheme of Arrangement

29 November 22

2022 Annual General Meeting

×

2022 Annual General Meeting

29 November 22

2022 AGM Results

×

2022 AGM Results

29 March 22

Appendix 3Y - W Coote

×

Appendix 3Y - W Coote

29 March 22

Appendix 3Y - P Wilson

×

Appendix 3Y - P Wilson

29 March 22

Appendix 3Y - L Dalton

×

Appendix 3Y - L Dalton

HLA Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.06 -0.03 0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.06 -0.03 0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock 54.1 -145.2 242.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 17.4 23.8 8.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 6.6 12.7 5.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.24 0.16 0.26 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.24 0.08 0.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.1 -32.6 57.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 12.0 5.4 8.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.04 0.02 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 128.5 -54.0 -100.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.2 1.6 3.6 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 69 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.82 1.06 1.09 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.65 -0.86 -0.81 Lock Lock Lock
     Growth % Lock Lock Lock Lock -22.7 -31.0 4.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 86 118 140 Lock Lock Lock
Basic m Lock Lock Lock Lock 83 118 136 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 137 200 253 Lock Lock Lock
     Growth % Lock Lock Lock Lock 57.0 46.2 26.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 14 20 24 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 26 30 51 Lock Lock Lock
     Growth % Lock Lock Lock Lock 97.5 16.9 67.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 19.0 15.2 20.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 81 85 80 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 27 32 52 Lock Lock Lock
     Growth % Lock Lock Lock Lock 99.5 21.8 61.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 19.4 16.2 20.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 14 21 25 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 12 11 27 Lock Lock Lock
     Growth % Lock Lock Lock Lock 246.3 -8.3 140.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.1 5.7 10.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 13 2 14 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 4 1 4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 5 -3 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 91.6 -164.6 264.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 3.8 -1.7 2.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 26 17 23 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 3 3 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -47 -84 -29 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 21 67 6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 23 14 15 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.5 -41.3 10.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 10 10 10 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 6 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 216 358 396 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 81 124 146 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 88 137 161 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 123 186 204 Lock Lock Lock
Equity $m Lock Lock Lock Lock 76 136 153 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 158 260 299 Lock Lock Lock
     Growth % Lock Lock Lock Lock 72.9 65.1 14.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 2.4 -0.9 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 6.8 -2.4 3.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 8.3 4.5 8.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.1 -1.6 2.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 21.1 8.2 8.1 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 7.2 5.5 5.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.3 4.2 3.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 115.6 100.8 105.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.7 0.7 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.5 0.5 0.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 23.0 15.9 12.8 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 70.5 32.6 43.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 24.5 30.6 23.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 18.9 18.3 16.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.9 2.2 2.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.6 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.6 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 9.6 0.8 5.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 6.1 0.4 3.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 30.2 78.4 27.5 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 2.4 -0.9 1.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.8 2.6 2.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 6.8 -2.4 3.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 30.5 170.7 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 2.1 -4.2 3.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 19.3 19.9 22.4 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 14.9 11.9 15.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 34.2 31.8 37.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 8.6 8.8 8.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 25.6 23.0 29.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

3.6%

Franking Level

100%

DPSg

-100.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HLA Shortsell

Frequently Asked Questions

The current share price of Healthia Ltd (HLA:ASX) is AU$1.8.
The 52-week high share price for Healthia Ltd (HLA:ASX) is AU$1.79.
The 52-week low share price for Healthia Ltd (HLA:ASX)? is AU$0.85.
The current TTM dividend payout for Healthia Ltd (HLA:ASX) is 3.60.
The last dividend payment of Healthia Ltd (HLA:ASX) is AU$0.02.
Healthia Ltd (HLA:ASX) has a franking level of 100%.
Healthia Ltd (HLA:ASX) is classified in the Healthcare.
The current P/E ratio for Healthia Ltd (HLA:ASX) is 8.90.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.